Shire, Barr In Talks To Settle Aderall XR Patent Challenge
U.K. drug maker Shire Pharmaceuticals is in talks with Barr Laboratories to try to settle out of court a patent challenge to Shire's blockbuster hyperactivity drug Adderall XR....To view the full article, register now.
Already a subscriber? Click here to view full article